NDC 0135-0607-01 - Panadol Cold and Flu NonDrowsy
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0135-0607
- Requested NDC
- 0135-0607-01
- Package NDCs from labels
- 0135-0607-01, 0135-0607-03, 0135-0607-02
- Manufacturer
- Haleon US Holdings LLC
- Effective date
- 2024-02-06
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Panadol Cold and Flu NonDrowsy - Haleon US Holdings LLC | Haleon US Holdings LLC | 2024-02-06 | HUMAN OTC DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 0135-0607-02 | 2020-07-22 | C162847 | 48780-1 | ab0e2407-34ee-f274-e053-dbdaa90a6471 | Drug Facts |
| 0135-0607-03 | 2020-07-22 | C162847 | 48780-1 | ab0e2407-34ee-f274-e053-dbdaa90a6471 | Drug Facts |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0135-0607-01 | PanadolCold and Flu NonDrowsy | 2 in 1 PACKET | TABLET, FILM COATED | 2 | 6 | |
| 0135-0607-02 | PanadolCold and Flu NonDrowsy | 3 in 1 CARTON | TABLET, FILM COATED | 3 | 6 | |
| 0135-0607-02 | PanadolCold and Flu NonDrowsy | 8 in 1 BLISTER PACK | TABLET, FILM COATED | 8 | 6 | |
| 0135-0607-03 | PanadolCold and Flu NonDrowsy | 50 in 1 CARTON | TABLET, FILM COATED | 50 | 6 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 0135-0607 | PANADOL COLD AND FLU NONDROWSY (ACETAMINOPHEN AND PHENYLEPRINE HCL) TABLET, FILM COATED [HALEON US HOLDINGS LLC] | 6 | Current NDC, Legacy NDC, 4 package rows | 20240207_f626ab17-01c9-4493-ba9e-0c8c11146384.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0135-0607-02 | EA - Each | 0135-0607 | 3d20babd-8f09-4f9a-a49a-c498993637c6 | 1 | 2022-12-07 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Adult Low Dose Enteric Coated Aspirin | ASPIRIN | Preferred Pharmaceuticals Inc. | 1b5b8bb1-c45d-48f0-b275-9ce1f769fed4 | 2026-03-09 | Warnings | M013 |
| sinus pressure and pain and cough | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, GUAIFENESIN, PHENYLEPHRINE HCL | Target Corporation | 488588f3-62d3-4248-937a-1c200792b5f1 | 2026-03-09 | Warnings | 04JA59TNSJ 362O9ITL9D |
| foster and thrive childrens pain and fever | ACETAMINOPHEN | Strategic Sourcing Services LLC | e495a27e-eb64-4c42-8942-43bab9918172 | 2026-03-07 | Warnings | M013 362O9ITL9D |
| Butalbital, Acetaminophen, and Caffeine | BUTALBITAL, ACETAMINOPHEN, AND CAFFEINE | Major Pharmaceuticals | 0ca49c3c-f2cb-40e3-a7d5-5f48eca59016 | 2026-03-06 | Boxed warning, Warnings, Adverse reactions | 362O9ITL9D |
| foster and thrive daytime severe cold and flu relief | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, PHENYLEPHRINE HYDROCHLORIDE | Sportpharm LLC | 51e34704-5e6b-4e80-836c-ddbc24a451b2 | 2026-03-06 | Warnings | 04JA59TNSJ 362O9ITL9D |
| Medi-First Plus Sinus Decongestant | PHENYLEPHRINE HYDROCHLORIDE | Sportpharm LLC | 20f58b0b-c123-477f-a62c-fa5423e23f93 | 2026-03-06 | Warnings | 04JA59TNSJ |
| Nasal Decongestant PE Maximum Strength | PHENYLEPHRINE HCL | Sportpharm LLC | 7f4e8d37-8c6b-4849-b86c-4335a0bcac1c | 2026-03-06 | Warnings | 04JA59TNSJ |
| good sense migraine formula | ACETAMINOPHEN, ASPIRIN, CAFFEINE | Sportpharm LLC | 2a27da49-23d6-4035-8088-806ee22b98b0 | 2026-03-06 | Warnings | 362O9ITL9D |
| hydrocodone bitartrate and acetaminophen | HYDROCODONE BITARTRATE AND ACETAMINOPHEN | Eywa Pharma Inc | 8a201e19-3e47-7e58-e053-2995a90ab1d5 | 2026-03-06 | Boxed warning, Warnings, Adverse reactions | 362O9ITL9D |
| Back and Body Pain Relief | ASPIRIN, CAFFEINE | WinCo Foods, LLC | cf5c15e9-c45d-4bd6-a887-fd74de5f81b9 | 2026-03-06 | Warnings | M013 |
| Nasal Decongestant PE | PHENYLEPHRINE HCL | Better Living Brands, LLC | 0153294d-7f52-4d92-8db8-daeca3e29a3b | 2026-03-06 | Warnings | 04JA59TNSJ |
| Childrens Pain and Fever | ACETAMINOPHEN | Topco Associates, LLC | 87af092c-99e6-475d-81af-b9fd8fc337d7 | 2026-03-06 | Warnings | M013 362O9ITL9D |
| Aspirin Regular Strength | ASPIRIN | Rite Aid Corporation | 879e2258-f61b-47ad-a4b1-7d1e78823570 | 2026-03-05 | Warnings | M013 |
| RYNEX PE | BROMPHENIRAMINE MALEATE AND PHENYLEPHRINE HCL | EDWARDS PHARMACEUTICALS, INC. | 77ae1cf6-b8e5-4f3c-b7bc-e2609a8991ef | 2026-03-05 | Warnings | 04JA59TNSJ |
| Oxycodone/APAP | OXYCODONE/APAP | Direct_Rx | e84245ca-957f-e85b-e053-2a95a90a836b | 2026-03-05 | Boxed warning, Warnings, Adverse reactions | 362O9ITL9D |
| cle de peau BEAUTE RADIANT FLUID FOUNDATION NATURAL B50 | OCTINOXATE AND TITANIUM DIOXIDE | SHISEIDO AMERICAS CORPORATION | 4490f968-46b6-44d2-af2d-5130b52c8861 | 2026-03-05 | Warnings | 15FIX9V2JP |
| Childrens Cold and Allergy | BROMPHENIRAMINE MALEATE, PHENYLEPHRINE HCL | Best Choice (Valu Merchandisers Company) | 042f9449-4af0-4b15-bb3e-236afeb1e11f | 2026-03-05 | Warnings | 04JA59TNSJ |
| Aspirin | ASPIRIN | ARMY AND AIR FORCE EXCHANGE SERVICE | 87c580d3-6009-4be9-aea7-13539fbe6e31 | 2026-03-05 | Warnings | M013 |
| Aspirin Low Dose Chewable Orange | ASPIRIN | MAJOR PHARMACEUTICALS | fb3a8e38-e991-49c9-93dc-1d29c0a97ba3 | 2026-03-05 | Warnings | M013 |
| AMAZON Childrens Multi Symptom Cold | DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE | AMAZON.COM SERVICES LLC | 26101105-a6cf-4b51-a639-9d078542fea3 | 2026-03-04 | Warnings | 04JA59TNSJ |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.